Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide injection versus Victoza in adults with type 2 diabetes
ChiCTR2100042889Phase 3Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Change in glycated hemoglobin from baseline. Started Feb 2021; status: recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2100042889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042889.